Address
Email address
GaeaOÜ is an agile full-service CRO in Phase I – III, IIT in all of Europe, with partners in the USA and Australia Read more Agile full-service CRO Commissioned by Sponsors, Gaea Trial Acceleration identifies and addresses the issues at sites, that are blocking their enrolment Read more Trial Enrolment Accelerator The GaeaOÜ CEO will work in-house at a company to define the clinical strategy and execute it with the company’s choice of CRO Read more Clinical Trial Planning
Name
Gaea Trial Acceleration OÜ
Registry code
14626223
VAT number
EE102126196
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
13.12.2018 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c.
260 615 €
20 691 €
8%
-
179 531 €
1
Submitted
No tax arrears
12%
8%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Nigel Gerard Goodman 24.05.1952 (72) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
2019 22.06.2020 | 2020 09.03.2021 | 2021 07.03.2022 | 2022 06.02.2023 | 2023 19.02.2024 | |
---|---|---|---|---|---|
Total Revenue | 130 543 € | 151 515 € | 209 124 € | 313 255 € | 260 615 € |
Net profit (loss) for the period | 85 266 € | 94 338 € | 145 615 € | 223 310 € | 20 691 € |
Profit Margin | 65% | 62% | 70% | 71% | 8% |
Current Assets | 66 721 € | 69 668 € | 75 946 € | 167 237 € | 262 765 € |
Fixed Assets | 815 € | 0 € | - | - | - |
Total Assets | 67 536 € | 69 668 € | 75 946 € | 167 237 € | 262 765 € |
Current Liabilities | 5 290 € | 14 554 € | 8 416 € | 8 397 € | 83 234 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 62 246 € | 55 114 € | 67 530 € | 158 840 € | 179 531 € |
Employees | 1 | 1 | 1 | 1 | 1 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 111 156.5 € | 3 264.32 € | 2 465.63 € | - |
2023 Q4 | 110 077.23 € | 2 683.68 € | 2 785.72 € | - |
2023 Q3 | 27 567.05 € | 1 471.03 € | 1 473.3 € | - |
2023 Q2 | 20 104.2 € | 2 012.76 € | 2 089.29 € | - |
2023 Q1 | 24 142.34 € | 2 012.76 € | 2 089.29 € | - |
2022 Q4 | 67 151.58 € | 11 012.76 € | 2 089.29 € | - |
2022 Q3 | 91 183.71 € | 10 567.1 € | 3 902.06 € | - |
2022 Q2 | 90 249.35 € | 10 393.23 € | 4 609.29 € | - |
2022 Q1 | 80 145.83 € | 7 599.74 € | 3 769.29 € | - |
2021 Q4 | 54 410.63 € | 11 012.76 € | 2 089.29 € | - |
2021 Q3 | 49 618.91 € | 10 987.5 € | 1 987.5 € | - |
2021 Q2 | 49 093.83 € | 10 707.05 € | 3 128.27 € | - |
2021 Q1 | 52 590.16 € | 10 653.83 € | 3 751.5 € | 1 |
2020 Q4 | 41 487.16 € | 11 668.34 € | 2 003.59 € | 1 |
2020 Q3 | 41 101.74 € | 8 055 € | 1 987.5 € | 1 |
2020 Q2 | 28 798.83 € | 7 199.35 € | 2 020.63 € | 1 |
2020 Q1 | 30 376.01 € | 5 440.41 € | 2 492.63 € | 1 |